Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia (Q62110987)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia |
clinical trial |
Statements
Treatment Protocol for Patients With Standard Risk Acute Myelogenous Leukemia and Its Variants: Induction Using High-Dose Cytarabine, Mitoxantrone and Ethyol; Consolidation With Cytarabine and Idarubicin and Maintenance With 13 Cis Retinoic Acid and Alpha Interferon (English)
0 references
April 1998
0 references
45
0 references